• Ticker

DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$34.56 $0.30 (0.88%)

REAL-TIME: Last trade at

Genomic Health

NASDAQ:GHDX

Genomic Health target raised to $43 from $33 at JMP Securities

Genomic Health Stays Neutral - Analyst Blog

Genomic Health Stays Neutral

An Early Look at 2012 ASCO Biotech Cancer Stocks (DNDN, LLY, AMGN, ARIA, ARQL, ARRY, AVEO, BVTI, ABPI, BMY, CLDX, CYTR, CYCC, GALE, EXEL, GNBT, GHDX, IMGN, MYGN, NKTR, NLNK, ONXX, OPTR, PCYC, SGEN, SNSS, SNTA)

Genomic Health Announces Presentation of Eighteen Studies Highlighting Progress in Breast, Colon and Prostate Cancers at the American Society of Clinical Oncology 2012 Annual Meeting

Genomic Health, Bob Evans Farms, Other Stocks Hit 52-Week Highs Tuesday

BreakoutStocks.com Reports 3 Companies Advancing In Today's Market - Groupon Inc, Genomic Health, and Zynga Inc

Genomic Health, Marriott Vacations Worldwide Among Stocks Setting 52-Week Highs Monday

Genomic Health management to meet with JPMorgan

5 Stocks Feeling the Insider Love

Taking An Early Look at 2012 ASCO Biotech/Cancer Stocks (DNDN, LLY, ARIA, ARRY, BVTI, ABPI, CLDX, CYTR, GALE, EXEL, GNBT, GHDX, IMGN, NKTR, NLNK, PCYC, SGEN)

Genomic Health Beats Estimates - Analyst Blog

Genomic Health Beats Estimates

Canaccord Genuity Maintains a 'Hold' on Genomic Health (GHDX); Raising PT and Estimates

OncoMed Taps Genomic Health to Identify Predictive Biomarkers for Anticancer Antibodies

Genomic Health, Inc. (GHDX) Tops Q1 EPS by 5c

Genomic Health, OncoMed announce strategic alliance

Genomic Health reports Q1 EPS 2c, consensus (3c)

Genomic Health to Announce First Quarter 2012 Financial Results and Host Conference Call on Wednesday, May 2, 2012

Dare to fail, Genomic Health boss tells Women in Bio

Positive Data from Genomic Health - Analyst Blog

Positive Data from Genomic Health

Myriad, Genomic Health weakness creates buying opportunity, says JMP Securities

Genomic Health (GHDX) to Report New Data from Recent Oncotype DX Clinicals

Genomic Health's Oncotype DX breast cancer test shows relevance in treatment

Genomic Health Announces Presentation of Three Oncotype DX® Studies at the 8th European Breast Cancer Conference

Genomic Health Announces Presentation of Three Oncotype DX® Studies at the 8th European Breast Cancer Conference

Supreme Court strikes down Nestle patents on autoimmune disease treatment

Biotech Trends: Analysts Expect Big Growth for Genetic Testing Industry (GHDX, ILMN, LIFE, MYGN)

4 Stocks With Heavy Insider Buying

Julian Baker raises stake in Genomic Health to 35.6% from 33.1%

Share and Share Alike

PerkinElmer Sues Waters for Infringing Mass Spec Patents

So Much for That

Agilent, BGI Developing Methodologies for 'Next-generation Super Exome'

A Number of Issues

DNA Dilemma

Roche Extends Tender Offer for Illumina

DNA in Play as Life Technologies Joins Illumina in Race for Deal: Real M&A

Genomic Health downgraded to Neutral from Buy at Garp Research

See More Articles...